MEK-ICS, The Republic of Korea - Komachine Supplier Profile and Product List

- MEK-ICS Co., Ltd. is a specialized intensive care medical device company, providing essential medical solutions for life support and respiratory treatment, including patient monitors, ventilators, CPAP devices, pulse oximeters, and central monitoring systems.MEK-ICS Co., Ltd. is a specialized intensive care medical device company, providing essential medical solutions for life support and respiratory treatment, including patient monitors, ventilators, CPAP devices, pulse oximeters, and central monitoring systems.
- **Ventilators**: Offers various models such as MV2000, MTV1000, MC3 (SU:M Series), HFT500, and MV50 (next-generation). These are high-performance universal ventilators featuring leak compensation with respiratory effort synchronization and a built-in turbine for self-generated air supply. Software-based product control allows for easy mode upgrades, and high-frequency ventilation (SHFV, DHFV) modes are available for patients with severely impaired lung function and pediatric care. Holds a patent for 'Artificial Respirator and its Control Method'.**Ventilators**: Offers various models such as MV2000, MTV1000, MC3 (SU:M Series), HFT500, and MV50 (next-generation). These are high-performance universal ventilators featuring leak compensation with respiratory effort synchronization and a built-in turbine for self-generated air supply. Software-based product control allows for easy mode upgrades, and high-frequency ventilation (SHFV, DHFV) modes are available for patients with severely impaired lung function and pediatric care. Holds a patent for 'Artificial Respirator and its Control Method'.
- **Patient Monitors**: Includes MP1300, MP1000NT PLUS, MP800, MP800C, MP570T, MP110P, MP111, MP601, and M3 series. Features a 12.1-inch touchscreen display and monitors various vital signs such as ECG, SpO2, NIBP, Respiration, IBP, and Temperature. Designed with a modular selection system for various physiological modules and provides a 72-hour graphical data memory for patient vital signs.**Patient Monitors**: Includes MP1300, MP1000NT PLUS, MP800, MP800C, MP570T, MP110P, MP111, MP601, and M3 series. Features a 12.1-inch touchscreen display and monitors various vital signs such as ECG, SpO2, NIBP, Respiration, IBP, and Temperature. Designed with a modular selection system for various physiological modules and provides a 72-hour graphical data memory for patient vital signs.
- **Continuous Positive Airway Pressure (CPAP) and High Flow Nasal Cannula (HFNC) Devices**: Offers CPAP product lines and the OmniOx series (HFT-750U, HFT-750, HFT-751). Incorporates Bi-Flow technology, a patented innovation (registered in Japan, pending in Korea) that adjusts flow rates according to the patient's breathing cycle to improve respiratory efficiency. This multi-functional platform integrates CPAP and Bi-Level functions, characterized by precise flow/pressure control technology, infection prevention design, and an intuitive user interface. Equipped with an internal battery for continuous treatment during patient transport.**Continuous Positive Airway Pressure (CPAP) and High Flow Nasal Cannula (HFNC) Devices**: Offers CPAP product lines and the OmniOx series (HFT-750U, HFT-750, HFT-751). Incorporates Bi-Flow technology, a patented innovation (registered in Japan, pending in Korea) that adjusts flow rates according to the patient's breathing cycle to improve respiratory efficiency. This multi-functional platform integrates CPAP and Bi-Level functions, characterized by precise flow/pressure control technology, infection prevention design, and an intuitive user interface. Equipped with an internal battery for continuous treatment during patient transport.
- **Central Monitoring System**: Provides the MeerKat Platform/System solution. Offers access to data from all patient devices, including patient monitors, ventilators, and high-flow respiratory devices. Allows for customizable screen configurations and enables patient status monitoring from anywhere within or outside the hospital via web browser and mobile app. Ensures 24/7 access with a reliable, state-of-the-art security system and fault-tolerant features.**Central Monitoring System**: Provides the MeerKat Platform/System solution. Offers access to data from all patient devices, including patient monitors, ventilators, and high-flow respiratory devices. Allows for customizable screen configurations and enables patient status monitoring from anywhere within or outside the hospital via web browser and mobile app. Ensures 24/7 access with a reliable, state-of-the-art security system and fault-tolerant features.
- **Leading with Korea's First and Only Respiratory Therapy Technology**: Pioneered the development and commercialization of the first domestic ventilator, the first domestic home CPAP device, and led domestic technology in patient monitoring systems, establishing itself as a trailblazer in the intensive care medical device market.**Leading with Korea's First and Only Respiratory Therapy Technology**: Pioneered the development and commercialization of the first domestic ventilator, the first domestic home CPAP device, and led domestic technology in patient monitoring systems, establishing itself as a trailblazer in the intensive care medical device market.
- **Comprehensive Respiratory Care Solutions**: Possesses a broad product lineup and IT solutions covering the entire spectrum of respiratory care, including ventilators, high-flow respiratory therapy devices, patient monitors, and central monitoring systems. Demonstrates capabilities as a total healthcare company serving both hospital and home care needs.**Comprehensive Respiratory Care Solutions**: Possesses a broad product lineup and IT solutions covering the entire spectrum of respiratory care, including ventilators, high-flow respiratory therapy devices, patient monitors, and central monitoring systems. Demonstrates capabilities as a total healthcare company serving both hospital and home care needs.
- **Global Market Expansion and Advanced Market Approvals**: Secured US FDA approval (OmniOx HFT-750U) and Japanese PMDA registration (HFT-750, HFT-751), establishing a foundation for entry into advanced medical markets. Exports to 42 countries across 7 continents, including Asia, the Middle East, and Europe, strengthening its global market position.**Global Market Expansion and Advanced Market Approvals**: Secured US FDA approval (OmniOx HFT-750U) and Japanese PMDA registration (HFT-750, HFT-751), establishing a foundation for entry into advanced medical markets. Exports to 42 countries across 7 continents, including Asia, the Middle East, and Europe, strengthening its global market position.
- **Continuous R&D and Innovative Technology Development**: Ensures competitiveness through the development of unique technologies such as the Bi-Flow function, with Japanese patent registration and ongoing domestic patent applications. Facilitates easy upgrade of treatment modes via software-based product control and actively pursues intelligent respiratory therapy solutions integrating advanced digital technologies like AI.**Continuous R&D and Innovative Technology Development**: Ensures competitiveness through the development of unique technologies such as the Bi-Flow function, with Japanese patent registration and ongoing domestic patent applications. Facilitates easy upgrade of treatment modes via software-based product control and actively pursues intelligent respiratory therapy solutions integrating advanced digital technologies like AI.
- **Premium Product Positioning Strategy**: Avoids competition based on low-cost models, instead focusing on a premium product strategy with advanced high-flow respiratory therapy functions to maximize profitability. Has a track record of supplying products at higher prices than global leading companies in demanding European markets like Italy.**Premium Product Positioning Strategy**: Avoids competition based on low-cost models, instead focusing on a premium product strategy with advanced high-flow respiratory therapy functions to maximize profitability. Has a track record of supplying products at higher prices than global leading companies in demanding European markets like Italy.
- **Direct Global Market Penetration through Localization Strategy**: Strengthens direct sales channels and promotes SKD (Semi Complete Knock Down) production through the establishment of local subsidiaries in India and Turkey. This strategy aims to diversify export structures and directly target overseas markets, securing local-based competitiveness.**Direct Global Market Penetration through Localization Strategy**: Strengthens direct sales channels and promotes SKD (Semi Complete Knock Down) production through the establishment of local subsidiaries in India and Turkey. This strategy aims to diversify export structures and directly target overseas markets, securing local-based competitiveness.
- Medical institutions (hospitals, intensive care units, emergency rooms, general wards)Medical institutions (hospitals, intensive care units, emergency rooms, general wards)
- Home care (treatment for sleep apnea and snoring, home-based rental services)Home care (treatment for sleep apnea and snoring, home-based rental services)
- Africa in generalAfrica in general
- India, Japan, China, Middle East, Asia in generalIndia, Japan, China, Middle East, Asia in general
- Italy, Turkey, Europe in generalItaly, Turkey, Europe in general
- United StatesUnited States
- **Patents**: Acquired patent rights for 'Artificial Respirator and its Control Method'. Completed Japanese patent registration for Bi-Flow function and has ongoing domestic patent applications.**Patents**: Acquired patent rights for 'Artificial Respirator and its Control Method'. Completed Japanese patent registration for Bi-Flow function and has ongoing domestic patent applications.
- **Certifications**: US Food and Drug Administration (FDA) approval (for high-performance hospital respiratory therapy device OmniOx HFT-750U). Japan Pharmaceuticals and Medical Devices Agency (PMDA) registration (for hospital HFT-750 and home-use HFT-751). Acquired medical device manufacturing license from the Ministry of Food and Drug Safety (for HFT750). Actively pursuing European CE(MDR) and Japanese Ministry of Health, Labour and Welfare (MHLW) new medical device registration simultaneously. Received New Health Technology certification for the 'SU:M Series' respiratory management system. Achieved safety conformity certification for the respiratory gas pathway through ISO 18562 biocompatibility evaluation.**Certifications**: US Food and Drug Administration (FDA) approval (for high-performance hospital respiratory therapy device OmniOx HFT-750U). Japan Pharmaceuticals and Medical Devices Agency (PMDA) registration (for hospital HFT-750 and home-use HFT-751). Acquired medical device manufacturing license from the Ministry of Food and Drug Safety (for HFT750). Actively pursuing European CE(MDR) and Japanese Ministry of Health, Labour and Welfare (MHLW) new medical device registration simultaneously. Received New Health Technology certification for the 'SU:M Series' respiratory management system. Achieved safety conformity certification for the respiratory gas pathway through ISO 18562 biocompatibility evaluation.